SCHEMBL7315206

SCHEMBL7315206

C[Si](C)(C)C#CCCCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 5/20 0.50
RECQL P46063 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MAPT P10636 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
USP2 O75604 1/20 0.50
POLB P06746 1/20 0.50
HPGD P15428 1/20 0.50
ALOX12 P18054 1/20 0.50
BLM P54132 1/20 0.50
KMT2A Q03164 1/20 0.50
MCL1 Q07820 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HMGCR P04035 3/20 0.48
LMNA P02545 2/20 0.42
SLC22A6 Q4U2R8 2/20 0.42
EPHX2 P34913 3/20 0.41
TSHR P16473 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL710828 0.94 PTPN7 (0.57) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL22029362 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL4060730 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL4063611 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL9551566 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL31682050 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL31682065 0.92 PTPN7 (0.60) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL6272882 0.86 EPHX2 (0.38) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL16968711 0.83 PTPN7 (0.35) PTPN7RECQLTDP1MAPTALDH1A1
SCHEMBL4969330 0.78 PTPN7 (0.64) PTPN7RECQLTDP1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0964851-A1 C-TERMINAL KETONE HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFA SECRETION Abbott Laboratories (US) 1999-12-22 EP disclosed
US-5985911-A COMBATTING DISEASE STATES INVOLVING TISSUE DEGENERATIVE PROCESSES I.E, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR ABBOTT LABORATORIES (US) 1999-11-16 US disclosed
WO-1998030541-A1 C-TERMINAL KETONE HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFA SECRETION ABBOTT LABORATORIES (US) 1998-07-16 WO disclosed
US-4602006-A Ynenolactone protease inhibitors SYNTEX (U.S.A.) INC. (US) 1986-07-22 US disclosed